ARCHIVES

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

This article is from The Cancer Letter archive.

Vol. 17 No. 31 | August 2, 1991

Download PDF Visit The Full Archive

Related Articles

John Durant Names ASCO Executive NP; A New Position, New Voice In Washington

December 2, 1994

Gonzalez-Angulo Found Guilty in MD Anderson Poisoning Case

September 26, 2014

NCI advisory Group, Other Cancer Meetings

March 29, 1985

Congress Investigates “Lecture Awards” To Former NCI Director Richard Klausner.

July 4, 2003

Hormonal Therapy Improves Prostate Cancer Survival

August 27, 2004

Sacharin Issue Splits Scientists; ACS Proposes Delaney Changes

April 15, 1977